Patents-Review.com
ClassID:

21480 ⎘

A61K49/101 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals

Sub-classes:
Recent Application in this class:
#1
20250129118
2025-04-24

MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE

 #2
20240251658
2024-07-25

METAL-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME

 #3
20240190897
2024-06-13

NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS

 #4
20230167154
2023-06-01

Melanocortin 1 receptor ligands and methods of use

 #5
20220259243
2022-08-18

IRON(III) AND GALLIUM(III) METAL ORGANIC POLYHEDRA, METHODS OF MAKING SAME, AND USES THEREOF

 #6
20220211879
2022-07-07

SOLVENT FREE GADOLINIUM CONTRAST AGENTS

 #7
20220047726
2022-02-17

FORMATION AND USES OF EUROPIUM

 #8
20210363161
2021-11-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

 #9
20210052749
2021-02-25

AMPHIPHILIC POLYMER NANO MICELLE CONTAINING POLY-3,4-DIHYDROXYPHENYLALANINE CHELATED FERRIC IONS

 #10
20210015948
2021-01-21

Manganese-based chelate conjugates for molecular MR imaging

 #11
20200371172
2020-11-26

Systems and Methods for Using Improved Contrast Agent in Performing and MRI

 #12
20200172800
2020-06-04

Luminescent particles based on rare earth elements and use thereof as a diagnostic agent

 #13
20200115391
2020-04-16

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

 #14
20200071341
2020-03-05

Preparation of a solid form of gadobenate dimeglumine

 #15
20200023082
2020-01-23

Formation and uses of europium

 #16
20200002376
2020-01-02

Melanocortin 1 receptor ligands and methods of use

 #17
20190365933
2019-12-05

Solvent-free gadolinium contrast agents

 #18
20190307903
2019-10-10

METHOD FOR MANUFACTURING A BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES, BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES

 #19
20190231907
2019-08-01

Metal complexes with bisphophonate or pyrophosphate useful as imaging agents

 #20
20190225625
2019-07-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

 #21
20190209713
2019-07-11

CEST systems exhibiting a concentration independent responsiveness

 #22
20190111160
2019-04-18

Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents

 #23
20190099496
2019-04-04

Composition intended to vectorise an anti-cancer agent

 #24
20190001003
2019-01-03

Manganese-based chelate conjugates for molecular MR imaging

 #25
20180303960
2018-10-25

Combination formulation

 #26
20180272010
2018-09-27

Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof

 #27
20180103890
2018-04-19

SYSTEM AND METHOD FOR IMAGING MACROPHAGE ACTIVITY USING DELTA RELAXATION ENHANCED MAGNETIC RESONANCE IMAGING

 #28
20170340757
2017-11-30

Targeted contrast agents comprising a hydrazide functional group

 #29
20170296681
2017-10-19

Compositions and methods for imaging

 #30
20170274102
2017-09-28

Post-surgical imaging marker

 #31
20170267699
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

 #32
20170267698
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

 #33
20170266304
2017-09-21

Metal complex formulations

 #34
20170218017
2017-08-03

Melanocortin 1 receptor ligands and methods of use

 #35
20170190719
2017-07-06

Preparation of a solid form of gadobenate dimeglumine

 #36
20170189562
2017-07-06

Metal complexes with bisphosphonate useful as imaging agents

 #37
20170057986
2017-03-02

Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species

 #38
20160296641
2016-10-13

Nanoparticle contrast agents for diagnostic imaging

 #39
20160045623
2016-02-18

Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI)

 #40
20160022842
2016-01-28

FORMATION AND USES OF EUROPIUM

 #41
20150335768
2015-11-26

ErbB-2 RECEPTOR TARGETING PEPTIDE

 #42
20150258221
2015-09-17

Paramagnetic solid lipid nanoparticles (pSLNs) containing metal amphiphilic complexes for MRI

 #43
20150231281
2015-08-20

Inflammation imaging and therapy

 #44
20150056137
2015-02-26

Caspase-triggered nano-aggregation probes and methods of use

 #45
20140112873
2014-04-24

Melanocortin 1 receptor ligands and methods of use

 #46
20140065076
2014-03-06

CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME

 #47
20130202538
2013-08-08

Molecular switch

 #48
20130195768
2013-08-01

CEST systems exhibiting a concentration independent responsiveness

 #49
20120213702
2012-08-23

NOVEL DIAGNOSTIC AGENTS FOR THE NON-INVASIVE IN VIVO IMAGING OF AMINOPEPTIDASE N (APN/CD13)

 #50
20120020886
2012-01-26

THERMAL SPIN CROSS-OVER COMPOUNDS AND METHODS OF USING SAME

 #51
20110293517
2011-12-01

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

 #52
20110117015
2011-05-19

Diagnostic agents selective against metalloproteases

 #53
20100233093
2010-09-16

Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes

 #54
20100061930
2010-03-11

ErbB-2 receptor targeting peptide

 #55
20060115431
2006-06-01

Procedures of cellular labelling with paramagnetic complexes for mri applications

 #56
20060078502
2006-04-13

Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents

 #57
20050276755
2005-12-15

Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate

 #58
20050220706
2005-10-06

Erb-2 receptor targeting peptide

 #59
20050008570
2005-01-13

Hydroxypyridonate and hydroxypyrimidinone chelating agents